Factors influencing the course of COVID-19 in the inflammatory rheumatic diseases

Clin Exp Rheumatol. 2023 Mar;41(3):758-759. doi: 10.55563/clinexprheumatol/3pcfrz. Epub 2022 Oct 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • COVID-19*
  • Humans
  • Rheumatic Diseases* / complications
  • Rheumatic Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • Antirheumatic Agents